Gut microbiome-derived propionate reprograms alveolar macrophages metabolically and regulates lung injury responses in mice
Responses to lung injury can vary between individuals with the diet and gut microbiome representing two underappreciated sources for this variability. The gut microbiome can influence lung injury outcomes through the gut‒lung axis, but exactly how diet and its effects on the microbiota are involved remains unclear. We hypothesized that dietary fiber interventions would favor the presence of short-chain fatty acid (SCFA)-producing fermentative bacteria presence in the gut microbiome, thereby influencing the resting lung immunometabolic tone as well as influencing downstream responses to lung injury and infection. To test this hypothesis, we fed mice fiber-rich (FR) and fiber-free (FF) diets, and observed changes in the steady-state transcriptional programming of alveolar macrophages (AM). Next, we examined the effects of the FR and FF diets on murine responses to sterile and infectious lung injury <i>in vivo</i> while simultaneously profiling the gut microbiota and SCFA levels transmitted along the gut‒lung axis. Finally, we validated our <i>in vivo</i> observations with mechanistic studies of the metabolic, signaling, and chromatin-modifying effects of specific SCFAs on lung AM <i>ex vivo</i> and <i>in vitro</i>. Overall, our fiber-rich diet reprogrammed AMs and attenuated lung inflammation after sterile injury while exacerbating lung infection. This effect of FR diets could be transferred to germ-free (GF) mice by fecal microbiome transplantation (FMT) and depended on the ability of the microbiota to produce propionate. Mechanistically, SCFAs altered the metabolic programming of AMs and lung tissue <i>ex vivo</i> without a clear role for free fatty acid receptors (FFAR) or chromatin remodeling. These findings demonstrate that the gut‒lung axis can regulate resting lung metabolic tone through dietary fiber intake and the enrichment of SCFA-producing gut bacteria, as well as influence sterile and non-sterile lung injury responses. These results provide evidence to support the development of therapeutic dietary interventions to preserve or enhance specific aspects of host pulmonary immunity.
Authors
- M. A. Matthay
- Hiroki Taenaka (ORCID: https://orcid.org/0000-0002-8643-8702)
- Tomohiro Chaki (ORCID: https://orcid.org/0000-0001-8898-3977)
- W. Liao
- Mazharul Maishan (ORCID: https://orcid.org/0000-0002-6374-7211)
- Xiaoli Tian
- Thien N. M. Doan
- Arun Prakash (ORCID: https://orcid.org/0000-0002-1424-0932)
- Daisuke Maruyama
Institutions
- Tri-Service General Hospital (TW)
- San Francisco General Hospital (US)
- Sapporo Medical University (JP)
- University of California, San Francisco (US)
- National Defense Medical Center (TW)
Publication Details
- Journal
- Gut Microbes
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1080/19490976.2025.2606486
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00